Delivery Order SPE2DR25D1109-SPE2DR26FFH4A
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets in a quantity of 100 units on November 13, 2025. This firm fixed-price delivery order, valued at $2,715.74, is scheduled for completion by November 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $3,071.22 delivery order to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100 count) under a firm fixed-price contract. The delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, was competitively awarded with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Levorphanol 2 mg tablets (100-count) with a firm fixed price ceiling value of $1,402.57. The contract is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Performance is located at AmerisourceBergen's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,606.83 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Levorphanol is an opioid analgesic used for pain management in military and federal healthcare...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Levorphanol Tablets 2mg, a controlled pharmaceutical product used in pain management. This firm fixed-price delivery order, valued at $8,422.31, was awarded without set-aside designation through competitive procurement and is scheduled for completion by June 25, 2025. The place of performance is AmerisourceBergen's corporate office location in...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,557.66 firm fixed-price contract is for the delivery of Levorphanol Tablets 2mg, a specialty medication, with a performance period through May 17, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,927.24 to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,830,114 tablets of 2 mg Levorphanol, a prescription medication, by June 7, 2024. This contract is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,884.79 firm fixed-price delivery order is for the supply of 4,563,788,623 units of Levorphanol 2 mg tablets, with a performance period running through February 23, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,190.73, is for the delivery of Levorphanol 2 mg tablets. The contract has an ultimate completion date of July 8, 2022 and is a Firm Fixed Price Delivery Order. No set-aside designation was used. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Levorphanol Tablets 2mg to the U.S. government. The contract, valued at $1,796.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The contract has a firm fixed price and a completion date of June 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH4ADelivery Order
The Defense Logistics Agency awarded a $2,715.74 delivery order to AmerisourceBergen Drug Corp for Levorphanol 2 mg tablets (100 count) under a firm fixed price contract. The order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a non-competitive, non-set-aside award to supply this pharmaceutical product to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through its extensive federal contract portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The Levorphanol tablets are part of AmerisourceBergen's broader pharmaceutical supply portfolio, which encompasses specialty medications, branded and generic drugs, and other critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/3/25 |